Liraglutide

Price range: $74.00 through $206.00

Liraglutide 5mg / 10mg / 30mg


What is LIRA

Liraglutide is supplied strictly for laboratory research and analytical applications, commonly referenced in metabolic pathway and receptor signaling studies.

Specifications:
  • Strength: 5 mg per vial
  • Format: Lyophilized powder
  • Category: Fat & Loss Metabolism
  • Documentation: COA available

Research Use Only — Not for Human Consumption.

SKU: N/A Category:

Description

  • About Liraglutide

    Liraglutide — the active ingredient in Victoza® and Saxenda® (CAS 204656-20-2) — is a long-acting GLP-1 receptor agonist with a C16 fatty acid chain (palmitoyl) attached via a glutamic acid linker to Lys²⁶, enabling reversible albumin binding and an extended half-life of ~13 hours (versus ~2 minutes for native GLP-1). It is supplied as a laboratory-grade lyophilized powder intended strictly for analytical and non-clinical research applications.

    Unlike native GLP-1(7-37), liraglutide is resistant to DPP-4 degradation due to Arg³⁴Lys and Lys²⁶ modifications. It activates GLP-1R (a Gs-coupled GPCR) to stimulate glucose-dependent insulin secretion, suppress glucagon, and delay gastric emptying. As the first once-daily GLP-1 agonist approved for both T2DM and obesity, liraglutide has extensive characterization across pancreatic β-cell, hypothalamic appetite circuit, and hepatic metabolic signaling research. Researchers use liraglutide in MIN6, INS-1, and primary islet models for β-cell GLP-1R/cAMP/PKA signaling studies, and in hypothalamic neuronal models (N41 cells) for appetite circuit mapping comparative to semaglutide and other next-generation GLP-1RAs.

    COMMON RESEARCH APPLICATIONS

    GLP-1R Pharmacology & β-Cell Signaling
    Used in MIN6, INS-1E, and HEK293-GLP1R models to study GLP-1R agonist-driven cAMP/PKA/CREB pathway activation, glucose-stimulated insulin secretion (GSIS) augmentation, β-arrestin recruitment, and receptor desensitization under once-daily dosing simulation protocols.

    Incretin Axis & Glucagon Suppression Research
    Tool compound for studying GLP-1R-mediated glucagon suppression in α-cell (αTC1-6) models and insulin/glucagon co-secretion dynamics in isolated islet models; used to map incretin axis signaling under normoglycemic vs. hyperglycemic challenge conditions.

    Hypothalamic Appetite Circuit Research
    Used in N41, GT1-7, and primary hypothalamic neuron models to study GLP-1R-driven POMC/CART pathway activation, NPY/AgRP suppression, and appetite-regulatory neural signaling at the arcuate nucleus level.

    Comparative GLP-1R Agonist Benchmarking
    First-generation long-acting GLP-1RA reference standard for comparing receptor activation kinetics, cAMP response magnitude, and β-arrestin bias ratios against semaglutide (C18 diacid), dulaglutide (IgG fusion), and next-generation GLP-1RAs in head-to-head receptor pharmacology studies.

  • Chemical Identity

    Compound Name: Liraglutide

    Internal Catalog Code: Liraglutide

    CAS Number: 204656-20-2

    Molecular Formula: C172H265N43O51

    Molecular Weight: 3751.20 g/mol

    Physical Properties

    Form/Appearance: Lyophilized powder

    Quality & Testing

    Purity: As listed on lot-specific COA

    Testing Method : HPLC (as applicable) · identity confirmation per COA

    Verification

    COA: Lot-specific, included with order (QR on label)

    Handling & Storage

    Storage Temperature: Store desiccated at −20°C for long-term; 2–8°C short-term. Protect from light. Refer to SDS/COA for compound-specific handling.

    Light Sensitivity: Protect from light

    Moisture: Store desiccated when applicable

    Available Strengths: 5 mg · 10 mg · 30 mg

    SKU (5 mg): VE-LIRA-005

    SKU (10 mg): VE-LIRA-010

    SKU (30 mg): VE-LIRA-030

    • What is this product?
      Liraglutide (Victoza®/Saxenda® active ingredient, CAS 204656-20-2, MW 3751.20 g/mol, C₁₇₂H₂₆₅N₄₃O₅₁) is supplied as a lyophilized long-acting GLP-1 receptor agonist for laboratory research use only. Available as VE-LIRA-005 (5 mg), VE-LIRA-010 (10 mg), and VE-LIRA-030 (30 mg).
    • What purity and testing methods are used?
      Each lot is tested by reverse-phase HPLC and MS confirmation to ≥98% purity with sequence verification. A lot-specific COA is included with every order, accessible via QR code on the label.
    • What are the key chemical identifiers?
      CAS 204656-20-2 · Molecular formula C₁₇₂H₂₆₅N₄₃O₅₁ · MW 3751.20 g/mol · Synonyms: Victoza active ingredient, Saxenda API, NN2211, liraglutide GLP-1 analog.
    • How is liraglutide reconstituted for research use?
      Dissolve in sterile water or PBS (pH 7.4) at ~1 mg/mL. DMSO (~5 mg/mL) may be used for organic solvent applications. Avoid repeated freeze-thaw cycles. Store desiccated at −20°C long-term. Protect from light.
    • What is the recommended storage upon receipt?
      Store immediately at −20°C desiccated. Short-term 2–8°C acceptable. Avoid repeated freeze-thaw. Inspect vials for integrity upon receipt.
    • What is a COA and why does it matter?
      A COA documents lot-specific purity (HPLC ≥98%), identity (MS), and sequence verification. Each liraglutide lot ships with a QR-accessible COA. Review before use to confirm identity and purity meet your experimental requirements.

Additional information

Dosage

10mg, 30mg, 5mg

Reviews

There are no reviews yet.

Be the first to review “Liraglutide”

Your email address will not be published. Required fields are marked *